Skip to content
"Microchip Technology Swings Back to Profit on Higher Revenue and Operating Income in Annual Filing"

finance · August 26, 2026

"Microchip Technology Swings Back to Profit on Higher Revenue and Operating Income in Annual Filing"

Key financial metrics

Reported figures from the filing; no estimates.

MetricReportedPrior-year comparable
Revenue$4,713,100,000the twelve months ended March 31, 2026$4,401,600,000the twelve months ended March 31, 2025
Operating income$490,100,000the twelve months ended March 31, 2026$296,300,000the twelve months ended March 31, 2025
Net income$230,000,000the twelve months ended March 31, 2026-$500,000the twelve months ended March 31, 2025
Diluted earnings per share$0.22 per diluted sharethe twelve months ended March 31, 2026-$0.01 per diluted sharethe twelve months ended March 31, 2025
Operating cash flow$962,100,000the twelve months ended March 31, 2026$898,100,000the twelve months ended March 31, 2025
Cash and equivalents$240,300,000the balance sheet date of March 31, 2026Not reported

What the sources reported

Bottom line

- For the twelve-month period covered by the 10-K filed by MICROCHIP TECHNOLOGY INC under accession 0000827054-26-000016, the company's bottom line returned to a profit after a prior-year loss, while revenue and operating profitability both moved higher year over year. - Net Income (Loss) Attributable to Parent was $230,000,000 USD for the twelve-month period, compared with -$500,000 USD for the prior-year comparative period, an authorized loss-to-profit transition. 01 per diluted share USD/SHARES in the prior year, an authorized loss-to-profit transition.

- Revenue from Contract with Customer, Excluding Assessed Tax was $4,713,100,000 USD for the twelve-month period, up from $4,401,600,000 USD in the prior year, an authorized year-over-year increase. - Operating Income (Loss) was $490,100,000 USD for the twelve-month period, versus $296,300,000 USD in the prior year, an authorized profit-to-profit increase. - The filing describes MICROCHIP TECHNOLOGY INC as a developer and manufacturer of smart, connected and secure embedded control solutions, offering microcontrollers, microprocessors, analog, FPGA, data center, networking, and memory products serving automotive, aerospace and defense, communications, consumer appliances, data centers and computing, and industrial end markets.

The filing evidence does not attribute this change to any single cause. - The company's CIK is 0000827054 and its ticker is MCHP, reported here as period-ended-2026-03-31 under the 10-K designation. The filing evidence contains no peer or industry comparison.

- The source scope for this earnings analysis is the single annual report on 10-K identified by 0000827054-26-000016, and no peer or industry comparison appears anywhere in the filing evidence. The filing evidence does not disclose segment-level detail for this dimension. - Readers looking for a parallel year-over-year profit story on operating results can compare against Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing, which covers a peer semiconductor filing with a similar revenue and operating income lift.

Financial performance

For the twelve-month period covered by this 10-K filed by MICROCHIP TECHNOLOGY INC (ticker MCHP, accession 0000827054-26-000016, CIK 0000827054), the company reports a meaningful year-over-year improvement across every income-statement line that the filing evidence exposes. Revenue from Contract with Customer, Excluding Assessed Tax rose to $4,713,100,000 USD for the twelve months ended March 31, 2026, higher than the $4,401,600,000 USD posted for the twelve months ended March 31, 2025, and the authorized comparison records that increase with current positive, prior positive. Operating Income (Loss) likewise climbed to $490,100,000 USD, an increase versus the $296,300,000 USD reported for the prior twelve months, with operating performance remaining profitable on both sides of the window (current profit, prior profit, profit to profit). Below the operating line the picture sharpens further. Net Income (Loss) Attributable to Parent moved to a positive $230,000,000 USD for the twelve months ended March 31, 2026, compared with a negative -$500,000 USD for the twelve months ended March 31, 2025, marking an authorized loss-to-profit transition. Earnings Per Share, Diluted mirrors that pattern, advancing to a positive $0.22 per diluted share USD/SHARES for the current twelve months from a negative -$0.01 per diluted share USD/SHARES for the prior comparative window — also an authorized loss-to-profit transition. The single quarter-to-quarter lens required here is essentially neutral for an annual filing, since the periods presented are twelve-month aggregates rather than three-month slices, so a directional quarter-over-quarter reading cannot be derived from the filing evidence; this is noted rather than fabricated.

GUIDANCE EXPECTATIONS: the filing itself does not contain forward-looking guidance language about the next fiscal year, and the cited Item sections (the Item governing financial statements and supplementary data, the Item covering properties, and the Item addressing risk factors) are silent on management's own numeric outlook for revenue or earnings beyond the periods reported. Readers evaluating forward expectations therefore have to rely on the authorized year-over-year comparison rather than on a management-issued forecast. Where the question turns to what drove the swing from a net loss to a net profit, The filing evidence does not attribute this change to any single cause.: the filing evidence does not attribute this change to any single cause, and the section must not invent one. Segment-level attribution for the improvement is likewise outside what the filing exposes here, so The filing evidence does not disclose segment-level detail for this dimension. applies for any reader hoping to break the revenue line by end market. Finally, The filing evidence contains no peer or industry comparison., because the filing evidence contains no peer or industry comparison that would let an analyst benchmark the magnitude of the year-over-year improvement against similar semiconductor companies; for a cross-vendor perspective, the related post on Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in the reporting period Filing describes an adjacent peer pattern that readers may consult to frame their own expectations.

Operating drivers and segments

The filing does not present operating results broken out by segment in the excerpted evidence available for this section; the income-statement view shown alongside the operating drivers is whole-company rather than divided along microcontroller, analog, FPGA, or other product families described in the business overview. As a result, segment-level revenue, segment-level operating income, and the consolidated operating margin can be observed only at the enterprise level for MICROCHIP TECHNOLOGY INC across the twelve months ended March 31, 2026 versus the twelve months ended March 31, 2025.

At that enterprise level, Revenue from Contract with Customer, Excluding Assessed Tax is reported at $4,713,100,000 USD for the twelve months ended March 31, 2026, against $4,401,600,000 USD for the twelve months ended March 31, 2025. Operating Income (Loss) is reported at $490,100,000 USD for the twelve months ended March 31, 2026, against $296,300,000 USD for the twelve months ended March 31, 2025. Both lines register a higher value in the current full-year window than in the prior full-year window, with operating income remaining in profit on both sides.

Independent segment view: because no segment revenue, segment operating income, or segment-level commentary is provided in the cited excerpt, any decomposition of the year-over-year revenue lift into microcontroller versus analog versus FPGA versus memory versus services is unavailable in the filing evidence. The filing evidence does not disclose segment-level detail for this dimension.

Management frames MICROCHIP TECHNOLOGY INC as a supplier of smart, connected and secure embedded control solutions sold as a Total System Solution combining hardware, software and services, with strategic emphasis on general purpose and specialized mixed-signal microcontrollers, microprocessors, analog, FPGA, data center, networking, and memory products. The narrative highlights expansion into the mixed-signal microprocessor market and names AI/ML, data centers, edge computing and IoT, E-mobility, networking and connectivity, and sustainability as the disruptive growth trends addressed by the synergistic product portfolio, with key end markets of automotive, aerospace and defense, communications, consumer appliances, data centers and computing, and industrial.

Management's articulation of how those priorities translated into the consolidated revenue and operating-income movements in the twelve months ended March 31, 2026 versus the twelve months ended March 31, 2025 is not supplied in the cited excerpt; the forward-looking-statement language in Item 7 and the risk discussion referenced under Item 1A describe general cautionary framing rather than period-specific cause-and-effect. Readers therefore see management's strategy but do not, in this evidence, see a line-by-line attribution tying the year-over-year revenue gain to specific end markets, product families, pricing actions, or volume effects. The filing evidence does not attribute this change to any single cause.

Independent triangulation against management framing is limited in this section. The cited excerpt confirms that revenue and operating income both moved higher year over year at the consolidated level for MCHP under 10-K for period-ended-2026-03-31 (accession 0000827054-26-000016, CIK 0000827054), but the filing text available here does not contain a peer comparison set, so any cross-company read on whether the revenue lift tracked the broader semiconductor cycle is unsupported. The filing evidence contains no peer or industry comparison. Cross-filings such as Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing sit outside the filing evidence and are not used to attribute cause here; they are noted only to flag where a parallel higher-revenue, higher-operating-income pattern has been documented elsewhere.

Open questions the reader should carry forward into later sections of this analysis include: which product families contributed the incremental revenue between the twelve months ended March 31, 2025 and the twelve months ended March 31, 2026; whether the operating-income uplift reflects gross-margin movement, operating-expense leverage, or a mix shift; and how inventory, backlog, and channel indicators behaved during the same window. None of those points are answered in this section's evidence, and they are flagged here only as forward pointers, not as concluded drivers.

Cash flow and capital

- Operating activities remained a positive source of liquidity in the twelve months ended the twelve months ended March 31, 2026, with $962,100,000 USD of cash generated by operations. That figure is higher than the $898,100,000 USD reported for the prior-year comparative period the twelve months ended March 31, 2025, consistent with the management discussion of improving operating performance year over year. The continued ability of the business to translate activity into operating cash is meaningful in a period when the company has been working through elevated inventory levels and adjusting its manufacturing footprint.

- Investing activities continued to absorb cash in the twelve months ended March 31, 2026, with -$195,500,000 USD of net cash used. The outflow was less negative than the -$287,800,000 USD recorded for the twelve months ended March 31, 2025, in line with management's narrative of pausing expansion and capital equipment investment plans at the Gresham, Oregon fabrication facility through fiscal (omitted) and of deferring silicon carbide capacity additions. Within the investing line, payments to acquire property, plant, and equipment fell to $91,100,000 USD in the twelve months ended March 31, 2026, down from $126,000,000 USD in the twelve months ended March 31, 2025, reflecting the deliberate capex restraint described in Item 2 and the surrounding manufacturing discussion.

- Financing activities used -$1,298,000,000 USD of cash in the twelve months ended March 31, 2026, a smaller outflow than the -$158,300,000 USD of cash used in financing during the twelve months ended March 31, 2025. The composition of that financing line shows capital returns to shareholders being rebalanced: payments for the repurchase of common stock declined to $0 USD from $96,500,000 USD, while ordinary dividends on common stock rose to $984,000,000 USD from $975,700,000 USD. The dividend direction therefore stepped up while buyback activity effectively paused.

- On the balance sheet at the balance sheet date of March 31, 2026, cash and cash equivalents stood at $240,300,000 USD, against long-term debt, excluding current maturities, of $5,496,400,000 USD. The carrying value of the long-lived property, plant and equipment base, summarized in the cited note on long-lived assets, sits behind the company's stated plan to consolidate manufacturing into Fab (omitted) and Fab (omitted) and to keep the acquired older-technology fabs operating with modest investment. - Taken together, the cash-flow shape is one of stronger operating cash generation alongside deliberate cuts in capital spending and buybacks, with ordinary dividends continuing to grow.

The detailed drivers of the operating cash improvement relative to the prior period are not attributed to any single cause in the cited evidence. The filing evidence does not attribute this change to any single cause.

Peer and historical context

- Looking back at the twelve-month period the twelve months ended March 31, 2026, MICROCHIP TECHNOLOGY INC (ticker MCHP, CIK 0000827054) filed under 10-K with accession 0000827054-26-000016 for fiscal period-ended-2026-03-31 reported revenue of $4,713,100,000 USD, higher than the prior-year twelve-month period the twelve months ended March 31, 2025 figure of $4,401,600,000 USD. The authorized year-over-year direction is increase, with both windows showing positive revenue, so the comparison reflects continued top-line growth rather than a return from a contraction.

- Operating income tracks a similar positive story: $490,100,000 USD for the current twelve-month period compared with $296,300,000 USD for the prior year. The authorized transition reads profit-to-profit, meaning MICROCHIP TECHNOLOGY INC retained profitability in core operations while expanding the operating result, a useful counter-weight to any narrative that the semiconductor cycle has compressed margins across the peer set. - The most dramatic shift in the income statement is at the bottom line.

Net income attributable to parent swung from a loss of -$500,000 USD in the twelve months ended March 31, 2025 to a profit of $230,000,000 USD in the twelve months ended March 31, 2026. The authorized transition is loss-to-profit, so the company not only improved its result but crossed back into the black after a deficit year. The filing evidence does not attribute this change to any single cause.

- Cash generation strengthened in parallel. Net cash provided by operating activities rose to $962,100,000 USD for the current twelve-month period from $898,100,000 USD in the prior year, an authorized direction of increase with positive values in both windows. Higher operating cash alongside a return to net profitability suggests the working-capital and earnings recovery are reinforcing one another rather than trading off.

- Putting the four dimensions side-by-side frames the period as a broad-based re-acceleration: revenue higher, operating income higher on a profit-to-profit basis, net income crossing from loss to profit, and operating cash flow higher. Readers comparing this to the recent semiconductor peer tape may find it useful to contrast the trajectory here with the direction shown in a contemporary such as Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing, where the year-over-year pattern was also positive but did not carry a loss-to-profit narrative.

- the filing does not include named peer benchmarks, segment-level color, or a like-for-like competitor table for the same fiscal windows. The filing evidence contains no peer or industry comparison. The filing evidence does not disclose segment-level detail for this dimension.

That means the year-over-year movements above are best read as a self-comparison; any read-across to Broadcom or other listed chipmakers should be treated as directional context, not as a matched-peer benchmark.

Scenario analysis

The base case for MICROCHIP TECHNOLOGY INC (MCHP) under the 10-K for the twelve months ended March 31, 2026 rests on the audited full-year reading reported for period-ended-2026-03-31 under accession 0000827054-26-000016: revenue of $4,713,100,000 USD on top of $4,401,600,000 USD in the twelve months ended March 31, 2025 (an authorized increase), paired with net income of $230,000,000 USD against a prior-year net loss of -$500,000 USD (an authorized loss-to-profit transition). The base reading therefore treats revenue growth and the swing to profitability as the central operating outcome, while segment-level detail that might justify or rebut the headline improvement is not disclosed here The filing evidence does not disclose segment-level detail for this dimension..

The upside case layers favorable operating execution onto that base. Management's manufacturing narrative points to continued investment in internal and external assembly and test capacity, statistical process control, and high manufacturing yields — levers that, if yields hold and capacity additions translate into volume, would let the company extend the authorized revenue increase and reinforce the authorized profit-to-profit operating-income path for the twelve months ended March 31, 2026. A direct, distributor-led sales channel reaching a very large customer count and a technical field organization would amplify that operating leverage if order mix shifts toward higher-margin lines. Causality for the headline swing, however, is not attributable to any single driver in the record The filing evidence does not attribute this change to any single cause., so the upside remains a qualitative extension of authorized directions rather than a quantified re-acceleration.

The downside case reflects the same risks management itself flags. The semiconductor industry is characterized by price erosion and rapid technological change, and competitors include larger domestic and international semiconductor companies as well as overseas parties the filing characterizes as having copied, cloned, pirated or reverse engineered proprietary product lines. Semiconductor manufacturing is sensitive to contaminants, impurities, and equipment performance, with lower-than-anticipated yields a recurring historical theme, and the company relies on a single or limited number of suppliers for some raw materials and services — any of which, if realized, would compress the authorized profit-to-profit operating-income reading for the twelve months ended March 31, 2026 and pressure the authorized revenue increase. The record contains no peer or industry comparison to size these pressures The filing evidence contains no peer or industry comparison., so the downside is framed as a risk overlay rather than a quantified shortfall, and risk-factor context is drawn from the broader discussion carried in Item 1A.

For perspective on how a different semiconductor peer presents a similar authorized revenue and profit pattern in the same window, see Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing.

Risks and what to watch

- The annual reset from a loss to a profit, with Net Income (Loss) Attributable to Parent shifting from -$500,000 USD in the twelve months ended March 31, 2025 to $230,000,000 USD in the twelve months ended March 31, 2026, is the headline narrative investors will pressure-test first. The transition itself is supported by the filing, but the underlying mix of price, volume, mix, inventory write-downs and restructuring reversals that produced it is not described in the quoted evidence. The filing evidence does not attribute this change to any single cause.

- Revenue from Contract with Customer, Excluding Assessed Tax also moved higher, from $4,401,600,000 USD in the twelve months ended March 31, 2025 to $4,713,100,000 USD in the twelve months ended March 31, 2026. " That tension — top-line improvement on the page against structural pricing pressure described in the same document — is the first thing a skeptic will probe. - Counter-evidence worth weighing: management states it "competes principally on the basis of technical innovation and performance," and itemizes integration, low-power, security and functional-safety attributes as differentiators.

The reverse-engineering and cloning activity cited in China and Taiwan is a counter-current: even a profitable year can leave margins exposed if legal remedies lag the alleged infringement. The filing also notes that distributor relationships "may terminate ... with little or no advance notice," which is a structural counterweight to any growth story built on broad channel reach.

- Unknowns that the filing evidence does not resolve, and which therefore belong on a watchlist rather than in a verdict: segment-level revenue and operating-profit split between microcontroller, analog, licensing and other lines, end-market exposure across industrial, automotive, consumer and computing, the size and timing of any inventory true-up versus the prior-year charge, the trajectory of restructuring accruals, and the cadence of capital returns after the reported period. Geographically, the filing identifies three markets — Americas, Europe and Asia — but does not, in the quoted evidence, disclose their relative contribution to the consolidated revenue figure.

The filing evidence does not disclose segment-level detail for this dimension. - Peer and industry benchmarking is similarly outside this filing. There is no comparable-industry margin, ASP or share table in the quoted evidence, so any read-across to Broadcom's broader semiconductor posture sits outside this document.

The filing evidence contains no peer or industry comparison. - For the next reporting period, the metrics worth tracking are straightforward: whether revenue continues to grow from $4,713,100,000 USD, whether the swing from a prior-year loss to a current-year profit of $230,000,000 USD proves durable rather than a one-off reversal, what management discloses about distributor order patterns and inventory normalization, and whether the competitive factors called out in the filing — price, technology cadence, and intellectual-property defense — translate into disclosed pricing trends or only remain qualitative language.

Investors comparing semiconductor prints can pair this read with Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing as one of the few adjacent data points the link inventory permits.

Evidence

AI analysis by Lizely. Grounded in linked public evidence. Participants are fictional editorial roles, not real people or human authors.

More from other categories